Sp811
CAN ESD REPLACE EMR IN THE GI TRACT? AN EVIDENCE-BASED ASSESSMENT
Date
May 8, 2023
Explore related products in the following collection:
Society: AGA
This clinical symposium will focus on the current state of the art for advanced tissue resection techniques (specifically ESD) and strategies for achieving the goal of reimbursement. ESD and third-space endoscopy has become a mainstay in the western world over the last 5-10 years but innovation in this field has been curbed due to lack of reimbursement. Tri-society attempts at obtaining a dedicated CPT code have met numerous road blocks and have left this critical field in endoscopy stifled. For the growing number of gastroenterologists now performing ESD, a pathway to reimbursement remains the hottest topic on their minds and a thoughtful clinical symposium focused on this issue would be unique and highly attended.
This clinical symposium will focus on the current state of the art for advanced tissue resection techniques (specifically ESD) and strategies for achieving the goal of reimbursement. ESD and third-space endoscopy has become a mainstay in the western world over the last 5-10 years but innovation in this field has been curbed due to lack of reimbursement. Tri-society attempts at obtaining a dedicated CPT code have met numerous road blocks and have left this critical field in endoscopy stifled. For the growing number of gastroenterologists now performing ESD, a pathway to reimbursement remains the hottest topic on their minds and a thoughtful clinical symposium focused on this issue would be unique and highly attended.
Presenter
Mayo Clinic-Jacksonville
Tracks
Related Products
HOW TO CREATE A BUSINESS CASE FOR IMPLEMENTATION AND GROWTH OF NEW TECHNOLOGY INTO A HOSPITAL SYSTEM
This session will provide attendees with the knowledge and skills to successfully create and implement new technology into their practices through negotiation with payors and securing support from hospital systems…
INTRODUCTION
SOCIETY: AGA
PLACEHOLDER
Perturbations in the gut mucosal immune response contributes to IBD. Non-immune cell popopulations including epithelial and stromal cells also play an important role in intestinal inflammation…
HABITUAL MEAT INTAKE IS ASSOCIATED WITH INCREASED RISK OF DISEASE FLARE IN ULCERATIVE COLITIS: INITIAL RESULTS FROM THE PREDICCT STUDY
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
